Services for Unit-Dose Nasal Drug Development
Expertise, Tools, and Methodologies for Making Informed Decisions
The development of a successful unit-dose nasal spray or powder is an intricate process that requires a thorough understanding of the interactions between formulation, device, and human usage. Our focused expertise, tools, and methodologies, gained from 25 years of experience with orally inhaled and nasal drug products (OINDPs), provide insight and understanding for making informed decisions to accelerate product success.
Contract test services, performed in our cGMP-compliant lab, evaluate the complex relationships between formulation, device, and human usage. Human actuation studies are carried out with trained testers on patented Ergo™ technology and screening experiments are executed following the controlled Proveris by Design™ approach. Viota® Unit-Dose Software is optimized to control the unique requirements of unit-dose devices resulting in increased accuracy and precision, in a robust format. We work with spray, syringe, pressurized aerosol devices and both liquid and powder formulations for systemic (central nervous system, immune system), nose-to-brain, and local delivery.
Human Actuation Studies
request a callback
From a Proveris Sales Associate